Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
19 May 2016
Header
Header image
News

News

International Clinical Trials Day: Celebrating the Foundation for Future Progress
19 May 2016

Europe stands on the brink of an R&D revolution, with the new Clinical Trials Regulation set to streamline the application and supervision processes, thereby boosting [...] Read more

From our blog

From our blog

Designing Clinical Trials Tools with Patient-Centricity in Mind (Guest blog)
19 May 2016 by Mitchell Silva

As a rare disease patient, wanting to participate in a clinical trial, I experienced how timely and hard it was to get access to the information I needed in order actually to participate in a trial. In some way, I was lucky, as I was working with some professors at the University of Leuven, Belgium, who – at the time of diagnosis – told me to keep track of a particular molecule that was in phase II. 

Read more

From our blog

Celebrating International Clinical Trials Day: improving people lives (Guest blog)
19 May 2016 by Kim Domela Kjøller

For many, 20 May is a day like any other – but for organisations and professionals worldwide working with scientific research, this day is an opportunity to acknowledge the achievements from healthcare research and how this may continue to improve people’s lives. Here, one parameter stands out as a key opportunity for the industry to work together: transparency in clinical trials data.

Read more

From our blog

Patients are in the driving seat delivering cutting-edge, patient-centric research the market needs (Guest blog)
19 May 2016 by Eric Low

While every decade has, to varying degrees, challenged the pharmaceutical industry to evolve, the current economic, political, and market access environment has removed any remaining doubt – if there were any – that change is now a matter of life or death for the pharmaceutical industry.

Read more

From our blog

Shining a Light on IMI’s Dedication to the Clinical Trials Process
19 May 2016 by Magda Chlebus

The Innovative Medicines Initiative’s work on expanding the use of big and real world data has been well documented – not least on this website. While big data is an extremely important part of the future direction of medical research, this does not mean that the clinical trial (CT) is a thing of the past. 

Read more

Videos

Video

TTIP: What's in it for patients?

The Transatlantic Trade and Investment Partnership (TTIP) aims to create more open trade between the EU and the US. Strengthening the world’s most important trading relationship can serve as a key platform to bring quicker new treatment options to patients. TTIP has the potential to facilitate the development of new medicines and deliver better and faster health outcomes to patients.

Researching and developing medicines is an increasingly collaborative and global process: pharmaceutical companies, academic institutions and healthcare systems from all over the world work together to develop new and innovative medicines. By reducing the need to do things twice, TTIP can help them stimulate, drive and deliver the treatments that patients need, not only in Europe and the US but also worldwide.

View video

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Events Calendar

EBE webinar: BioSimilars Labelling
On 26/05/2016

The European Biopharmaceutical Enterprises (EBE) and the European Association for Bioindustries (EuropaBio) organised a multi-stakeholder Biosimilar Labelling workshop in Brussels on 2 February 2016.
 
The main aim of the workshop was to gain an understanding of how stakeholders use or consult medicinal product information and to investigate their preferences regarding the content of biosimilar labels. The focus was on perspectives of end-users of product labels, namely patients, physicians and pharmacists. During the workshop, reference was made to ‘the label’ without further specification. From the context of the discussion, this may mean the label on the outer packaging of the product, the Summary of product Characteristics (SmPC), the Patient Leaflet (PL) or all elements of the product literature.

Read more

Events Calendar

European Conference on Rare Diseases & Orphan Products 2016
From 26/05/2016 to 28/05/2016 (Edinburgh, Scotland)

Following on from seven successful events, 2016 sees the 8th year of the ever-growing European Conference on Rare Diseases & Orphan Products. This biennial conference is a unique opportunity to come together and exchange views and experiences: it is the event at which to connect and share with all other members of the rare disease community.

The focus in 2016, will be on Game Changers in Rare Diseases. We will also be holding pre-conference tutorials, which will ensure that you are equipped to learn as much as possible from the conference.

For more information about the programme, click here.

Read more

Events Calendar

Falsified Medicines - a Joint TOPRA/DIA Meeting
On 06/06/2016 (Brussels)

Take stock of where we stand in the EU on falsified medicines and paint the landscape of the global issue

Attend this essential conference to hear from key speakers who will present the approaches of the Member States on the implementation of the new legislation, and the impact and achievements of the concerned stakeholders such as industry, patients, pharmacies and distributors who have worked independently and together to find solutions. 

Read more

What we are reading

What we are reading

ABPI, EFPIA and IFPMA issue joint statement following publication of the final report by the Review on AMR
19 May 2016 (ABPI)

The Association of the British Pharmaceutical Industry (ABPI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) have today issued a joint statement following the publication of the final report by the Review on Antimicrobial Resistance (AMR), led by Lord O’Neill.

Read more

What we are reading

Major new report reveals socio-economic impact of Innovative Medicines Initiative projects
19 May 2016 (IMI)

Innovative Medicines Initiative (IMI) projects are generating socio-economic impacts on a number of fronts, reveals a major new analysis by independent experts. The report shows how the first projects launched by IMI are making concrete improvements to pharmaceutical research and development (R&D); leveraging funding; creating new knowledge and tools; and making Europe an attractive place to carry out research. Importantly the report notes that many of the projects’ achievements would not have been possible without IMI.

Read more

What we are reading

CPME Newsletter - May 2016
19 May 2016 (CPME)

You can read the new edition of the CPME newsletter here.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail